These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 34797324)

  • 1. Efficacy of sequential N-butylphthalide therapy on psychiatric and behavioral functions in acute ischemic stroke.
    Yang L; Li H; Wu Y; Zhang H; Du J; Chen Y
    Medicine (Baltimore); 2021 Nov; 100(46):e27860. PubMed ID: 34797324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ninety-day administration of dl-3-n-butylphthalide for acute ischemic stroke: a randomized, double-blind trial.
    Cui LY; Zhu YC; Gao S; Wang JM; Peng B; Ni J; Zhou LX; He J; Ma XQ
    Chin Med J (Engl); 2013; 126(18):3405-10. PubMed ID: 24034079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy and safety of Dl-3n-butylphthalide on progressive cerebral infarction: A randomized controlled STROBE study.
    Zhang C; Zhao S; Zang Y; Gu F; Mao S; Feng S; Hu L; Zhang C
    Medicine (Baltimore); 2017 Jul; 96(30):e7257. PubMed ID: 28746179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of butylphthalide for patients who had acute ischaemic stroke receiving intravenous thrombolysis or endovascular treatment (BAST trial): study protocol for a randomised placebo-controlled trial.
    Zhang X; Wang A; Zhang JY; Jia B; Huo X; Zuo Y; Tian X; Wang Y; Miao Z;
    BMJ Open; 2021 May; 11(5):e045559. PubMed ID: 34035100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of Dl-3-n-Butylphthalide Combined With Human Urinary Kallidinogenase in the Treatment of Acute Ischemic Stroke.
    Zhang Y; Zhou F; Li H; Lei J; Mo Z; Li G; Wang J
    Clin Neuropharmacol; 2023 Mar-Apr 01; 46(2):60-65. PubMed ID: 36790373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mobilization of Circulating Endothelial Progenitor Cells by dl-3-n-Butylphthalide in Acute Ischemic Stroke Patients.
    Zhao H; Yun W; Zhang Q; Cai X; Li X; Hui G; Zhou X; Ni J
    J Stroke Cerebrovasc Dis; 2016 Apr; 25(4):752-60. PubMed ID: 26775268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of butylphthalide in secondary prevention of stroke: study protocol for a multicenter, real world trial based on Internet.
    Lv J; Zhao D; Zhao G; Xie Z
    BMC Neurol; 2022 Aug; 22(1):305. PubMed ID: 35986234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DL-3-n-butylphthalide for acute ischemic stroke: An updated systematic review and meta-analysis of randomized controlled trials.
    Wang H; Ye K; Li D; Liu Y; Wang D
    Front Pharmacol; 2022; 13():963118. PubMed ID: 36120291
    [No Abstract]   [Full Text] [Related]  

  • 9. A Systematic Review of Neuroprotective Efficacy and Safety of DL-3-N-Butylphthalide in Ischemic Stroke.
    Xu ZQ; Zhou Y; Shao BZ; Zhang JJ; Liu C
    Am J Chin Med; 2019; 47(3):507-525. PubMed ID: 30966774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. dl-3-n-butylphthalide for alleviation of neurological deficit after combined extracranial-intracranial revascularization for moyamoya disease: a propensity score-matched analysis.
    Li Z; Lu J; Ma L; Wu C; Xu Z; Chen X; Ye X; Wang R; Zhao Y
    J Neurosurg; 2020 Feb; 132(2):421-433. PubMed ID: 30771781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-Butylphthalide vs. Human Urinary Kallidinogenase for the Treatment of Acute Ischemic Stroke: Functional Outcome and Impact on Serum VEGF and TNF-α Expressions.
    Guo Y; Abdoulaye IA; Liu F; Wang J; Tian X; Yu D; Le K
    Ann Clin Lab Sci; 2021 Jul; 51(4):503-511. PubMed ID: 34452888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Safety of Adherence to dl-3-n-Butylphthalide Treatment in Patients With Non-disabling Minor Stroke and TIA-Analysis From a Nationwide, Multicenter Registry.
    Tan Z; Zhao Y; Yang W; He S; Ding Y; Xu A
    Front Neurol; 2021; 12():720664. PubMed ID: 34630292
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy and safety comparison of DL-3-n-butylphthalide and Cerebrolysin: Effects on neurological and behavioral outcomes in acute ischemic stroke.
    Xue LX; Zhang T; Zhao YW; Geng Z; Chen JJ; Chen H
    Exp Ther Med; 2016 May; 11(5):2015-2020. PubMed ID: 27168844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of l-3-n-Butylphthalide within 24 h after intravenous thrombolysis for acute cerebral infarction.
    Wang M; Feng Y; Yuan Y; Gui L; Wang J; Gao P; Qin B; Sima D; Wang Q; Pan W
    Complement Ther Med; 2020 Aug; 52():102442. PubMed ID: 32951710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and Efficacy of Sovateltide (IRL-1620) in a Multicenter Randomized Controlled Clinical Trial in Patients with Acute Cerebral Ischemic Stroke.
    Gulati A; Agrawal N; Vibha D; Misra UK; Paul B; Jain D; Pandian J; Borgohain R
    CNS Drugs; 2021 Jan; 35(1):85-104. PubMed ID: 33428177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of DL-3-n-butylphthalide in patients with vascular cognitive impairment without dementia caused by subcortical ischemic small vessel disease: A multicentre, randomized, double-blind, placebo-controlled trial.
    Jia J; Wei C; Liang J; Zhou A; Zuo X; Song H; Wu L; Chen X; Chen S; Zhang J; Wu J; Wang K; Chu L; Peng D; Lv P; Guo H; Niu X; Chen Y; Dong W; Han X; Fang B; Peng M; Li D; Jia Q; Huang L
    Alzheimers Dement; 2016 Feb; 12(2):89-99. PubMed ID: 26086183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Efficacy of N-Butylphthalide and Dexamethasone Combined with Hyperbaric Oxygen on Delayed Encephalopathy After Acute Carbon Monoxide Poisoning.
    Zhang J; Guo Y; Li W; Li G; Chen Y
    Drug Des Devel Ther; 2020; 14():1333-1339. PubMed ID: 32308366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human urinary kallidinogenase or edaravone combined with butylphthalide in the treatment of acute ischemic stroke.
    Qian Y; Lyu Y; Jiang M; Tang B; Nie T; Lu S
    Brain Behav; 2019 Dec; 9(12):e01438. PubMed ID: 31638334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-3-n-Butylphthalide reduces ischemic stroke injury and increases M2 microglial polarization.
    Li F; Ma Q; Zhao H; Wang R; Tao Z; Fan Z; Zhang S; Li G; Luo Y
    Metab Brain Dis; 2018 Dec; 33(6):1995-2003. PubMed ID: 30117100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study Protocol for a Randomized, Double-Blind, Placebo-Controlled, Phase-II Trial: AdrenoMedullin for Ischemic Stroke Study.
    Yoshimoto T; Saito S; Omae K; Hattori Y; Fukuma K; Kitamura K; Kakuta R; Kita T; Maruyama H; Yamamoto H; Ihara M
    J Stroke Cerebrovasc Dis; 2021 Jun; 30(6):105761. PubMed ID: 33813084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.